184 related articles for article (PubMed ID: 32778061)
1. Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer - DIA-PANC study: study protocol for an international, multicenter, diagnostic trial.
Litjens G; Rivière DM; van Geenen EJM; Radema SA; Brosens LAA; Prokop M; van Laarhoven CJHM; Hermans JJ
BMC Cancer; 2020 Aug; 20(1):744. PubMed ID: 32778061
[TBL] [Abstract][Full Text] [Related]
2. Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI.
Riviere DM; van Geenen EJM; van der Kolk BM; Nagtegaal ID; Radema SA; van Laarhoven CJHM; Hermans JJ
Abdom Radiol (NY); 2019 May; 44(5):1756-1765. PubMed ID: 30659309
[TBL] [Abstract][Full Text] [Related]
3. Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study.
Görgec B; Hansen I; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bisschops RHC; Bollen TL; Bosscha K; Burgmans MC; Cappendijk V; De Boer MT; D'Hondt M; Edwin B; Gielkens H; Grünhagen DJ; Gillardin P; Gobardhan PD; Hartgrink HH; Horsthuis K; Kok NFM; Kint PAM; Kruimer JWH; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Morone M; Pennings JP; Peringa J; Te Riele WW; Vermaas M; Wicherts D; Willemssen FEJA; Zonderhuis BM; Bossuyt PMM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
BMC Cancer; 2021 Oct; 21(1):1116. PubMed ID: 34663243
[TBL] [Abstract][Full Text] [Related]
4. Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study.
Marion-Audibert AM; Vullierme MP; Ronot M; Mabrut JY; Sauvanet A; Zins M; Cuilleron M; Sa-Cunha A; Lévy P; Rode A
AJR Am J Roentgenol; 2018 Nov; 211(5):W217-W225. PubMed ID: 30240298
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT.
Jeon SK; Lee JM; Joo I; Lee DH; Ahn SJ; Woo H; Lee MS; Jang JY; Han JK
Eur Radiol; 2018 Aug; 28(8):3484-3493. PubMed ID: 29352379
[TBL] [Abstract][Full Text] [Related]
6. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
[TBL] [Abstract][Full Text] [Related]
7. Initial M Staging of Rectal Cancer: FDG PET/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT.
Yoon JH; Lee JM; Chang W; Kang HJ; Bandos A; Lim HJ; Kang SY; Kang KW; Ryoo SB; Jeong SY; Park KJ
Radiology; 2020 Feb; 294(2):310-319. PubMed ID: 31793850
[TBL] [Abstract][Full Text] [Related]
8. MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis.
Altmayer S; Armelin LM; Pereira JS; Carvalho LV; Tse J; Balthazar P; Francisco MZ; Watte G; Hochhegger B
Eur Radiol; 2024 Jan; 34(1):106-114. PubMed ID: 37566274
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer.
Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Aramaki T; Endo M; Uesaka K
Pancreatology; 2017; 17(3):451-456. PubMed ID: 28298257
[TBL] [Abstract][Full Text] [Related]
10. Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false negatives.
LeBlanc M; Kang J; Costa AF
Eur Radiol; 2023 Nov; 33(11):7656-7664. PubMed ID: 37266655
[TBL] [Abstract][Full Text] [Related]
11. MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial.
Görgec B; Hansen IS; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bosscha K; Burgmans MC; Cappendijk VC; D'Hondt M; Edwin B; van Erkel AR; Gielkens HAJ; Grünhagen DJ; Gobardhan PD; Hartgrink HH; Horsthuis K; Klompenhouwer EG; Kok NFM; Kint PAM; Kuhlmann K; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Meijerink M; Meyer Y; Morone M; Peringa J; Sijberden JP; van Delden OM; van den Bergh JE; Vanhooymissen IJS; Vermaas M; Willemssen FEJA; Dijkgraaf MGW; Bossuyt PM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
Lancet Oncol; 2024 Jan; 25(1):137-146. PubMed ID: 38081200
[TBL] [Abstract][Full Text] [Related]
12. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
[TBL] [Abstract][Full Text] [Related]
13. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.
Kim HW; Lee JC; Paik KH; Kang J; Kim YH; Yoon YS; Han HS; Kim J; Hwang JH
Surgery; 2017 Jun; 161(6):1579-1587. PubMed ID: 28237643
[TBL] [Abstract][Full Text] [Related]
15. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma.
Yamaguchi T; Sofue K; Ueshima E; Ueno Y; Tsujita Y; Yabe S; Shirakawa S; Toyama H; Hori M; Fukumoto T; Murakami T
J Magn Reson Imaging; 2022 Sep; 56(3):725-736. PubMed ID: 35005813
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE
Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057
[TBL] [Abstract][Full Text] [Related]
18. The added diagnostic value of complementary gadoxetic acid-enhanced MRI to
Puhr-Westerheide D; Cyran CC; Sargsyan-Bergmann J; Todica A; Gildehaus FJ; Kunz WG; Stahl R; Spitzweg C; Ricke J; Kazmierczak PM
Cancer Imaging; 2019 Nov; 19(1):73. PubMed ID: 31727170
[TBL] [Abstract][Full Text] [Related]
19. MRI of adenocarcinoma of the pancreas.
Miller FH; Rini NJ; Keppke AL
AJR Am J Roentgenol; 2006 Oct; 187(4):W365-74. PubMed ID: 16985107
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
